TrialHIV medicine2016

Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density.

J Natsag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.